Jupiter Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Jupiter Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$483K	Buy	+39,247	New	+$444K	0.01%	324

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jupiter Investment Management's TEVA Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2020: 39,247 shares worth $483K. The stake represents 0.01% of the portfolio and ranks #324 among its holdings.

455 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

Jupiter Investment Management held 39,247 shares of Teva Pharmaceuticals worth $483K as of Q2 2020.
Teva Pharmaceuticals was a new Jupiter Investment Management position in Q2 2020.
Teva Pharmaceuticals made up 0.01% of Jupiter Investment Management's portfolio in Q2 2020, its #324 holding.
455 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.